Identification and in vivoefficacy assessment of approved orally bioavailable human host protein-targeting drugs with broad anti-influenza a activity
10.3389/fimmu.2019.01097
Saved in:
Main Authors: | Enkirch, T., Sauber, S., Anderson, D.E., Gan, E.S., Kenanov, D., Maurer-Stroh, S., Von Messling, V. |
---|---|
Other Authors: | BIOLOGICAL SCIENCES |
Format: | Article |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/210832 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Update on influenza anti-virals
by: Tambyah, P.A.
Published: (2011) -
Influenza passaging annotations: what they tell us and why we should listen
by: DuPai, C.D., et al.
Published: (2022) -
Oseltamivir-resistance detection of avian influenza H5N1 and molecular genetics of influenza A virus in Thailand
by: Salin Chutinimitkul
Published: (2012) -
Assessment of knowledge and preventive behavior against influenza A (H1N1) among international students at Chulalongkorn University
by: Omelihu, Melvin Ngozi
Published: (2011) -
Computational analysis of the receptor binding specificity of novel influenza A/H7N9 viruses
by: Zhou, Xinrui, et al.
Published: (2018)